Edition:
India

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

6.09USD
9:49pm IST
Change (% chg)

$-0.22 (-3.49%)
Prev Close
$6.31
Open
$6.08
Day's High
$6.10
Day's Low
$6.08
Volume
1,601
Avg. Vol
8,902
52-wk High
$10.75
52-wk Low
$3.04

Latest Key Developments (Source: Significant Developments)

BiondVax and NIH sign clinical trial agreement for phase 2 trial for universal flu vaccine
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Biondvax Pharmaceuticals Ltd :BiondVax and NIH sign clinical trial agreement for a phase 2 trial in the U.S. with BiondVax's universal flu vaccine.BiondVax Pharmaceuticals - ‍NIAID is submitting IND to FDA, participant recruitment anticipated to begin after end of 2017/18 flu season​.  Full Article

Biondvax Pharmac files for stock shelf of up to $150 mln
Friday, 4 Nov 2016 

Biondvax Pharmaceuticals Ltd :Biondvax pharmaceuticals ltd - files for stock shelf of up to $150 million - sec filing.  Full Article

Biondvax reports Q2 loss per share NIS 0.02
Friday, 19 Aug 2016 

Biondvax Pharmaceuticals Ltd : Announces second quarter 2016 financial results and update .Qtrly loss per share NIS 0.02.  Full Article

BRIEF-BiondVax and NIH sign clinical trial agreement for phase 2 trial for universal flu vaccine

* BiondVax and NIH sign clinical trial agreement for a phase 2 trial in the U.S. with BiondVax's universal flu vaccine